Chemours Co is trading 4.1% down at $20.78 following a federal appeals court decision regarding chemical discharges and broader market volatility.

  • The stock is extending a multi-session decline after a court ruling tied to environmental discharges at its Washington Works plant.
  • Selling pressure is being amplified by a sharp sell-off in U.S. equity markets as investors weigh the impact of higher-for-longer interest rates.